Home NKX2-1 mutations in brain-lung-thyroid syndrome: a case series of four patients
Article
Licensed
Unlicensed Requires Authentication

NKX2-1 mutations in brain-lung-thyroid syndrome: a case series of four patients

  • Vinutha B. Shetty EMAIL logo , Cathy Kiraly-Borri , Phillipa Lamont , Hennie Bikker and Catherine S.Y. Choong
Published/Copyright: October 16, 2013

Abstract

Brain-lung-thyroid syndrome (BLTS) characterized by congenital hypothyroidism, respiratory distress syndrome, and benign hereditary chorea is caused by thyroid transcription factor 1 (NKX2-1/TTF1) mutations. We report the clinical and molecular characteristics of four cases presenting with primary hypothyroidism, respiratory distress, and neurological disorder. Two of the four patients presenting with the triad of BLTS had NKX2-1 mutations, and one of these NKX2-1 [c.890_896del (p.Ala327Glyfs*52)] is a novel variant. The third patient without any identified NKX2-1 mutations was a carrier of mitochondrial mutation; this raises the possibility of mitochondrial mutations contributing to thyroid dysgenesis. Although rare, the triad of congenital hypothyroidism, neurological, and respiratory signs is highly suggestive of NKX2-1 anomalies. Screening for NKX2-1 mutations in patients with thyroid, lung, and neurological abnormalities will enable a unifying diagnosis and genetic counseling for the affected families. In addition, identification of an NKX2-1 defect would be helpful in allaying the concerns about inadequate thyroxine supplementation as the cause of neurological defects observed in some children with congenital hypothyroidism.


Corresponding author: Vinutha B. Shetty, Department of Endocrinology, Princess Margaret Hospital for Children, GPO Box D184, Perth, WA 6840, Australia, Phone: +61 4 28325867, Fax: +61 8 93408605, E-mail: ; School of Paediatrics and Child Health, The University of Western Australia, Perth, WA, Australia

Acknowledgments

We thank Dr. Barry. D. Lewis, the head of Clinical Biochemistry at Princess Margaret Hospital for Children, Perth, Western Australia for facilitating the genetic testing of these families.

Conflict of interest statement

The authors have nothing to disclose.

References

1. Damante G, Tell G, Di Lauro R. A unique combination of transcription factors controls differentiation of thyroid cells. Prog Nucleic Acid Res Mol Biol 2001;66:307–56.Search in Google Scholar

2. Zannini M, Avantaggiato V, Biffali E, Arnone MI, Sato K, et al. TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO J 1997;16:3185–97.Search in Google Scholar

3. Guazzi S, Price M, De Felice M, Damante G, Mattei MG, et al. Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J 1990;9:3631–9.Search in Google Scholar

4. Pan Q, Li C, Xiao J, Kimura S, Rubenstein J, et al. In vivo characterization of the Nkx2.1 promoter/enhancer elements in transgenic mice. Gene 2004;331:73–82.Search in Google Scholar

5. Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, et al. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 1996;10:60–9.Search in Google Scholar

6. Pohlenz J, Dumitrescu A, Zundel D, Martine U, Schonberger W, et al. Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice. J Clin Invest 2002;109:469–73.Search in Google Scholar

7. Olivieri A, Stazi MA, Mastroiacovo P, Fazzini C, Medda E, et al. A population-based study on the frequency of additional congenital malformations in infants with congenital hypothyroidism: data from the Italian Registry for Congenital Hypothyroidism (1991–1998). J Clin Endocrinol Metab 2002;87:557–62.Search in Google Scholar

8. Polak M, Sura-Trueba S, Chauty A, Szinnai G, Carre A, et al. Molecular mechanisms of thyroid dysgenesis. Horm Res 2004;62:14–21.Search in Google Scholar

9. Devriendt K, Vanhole C, Matthijs G, de Zegher F. Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respiratory failure. N Engl J Med 1998;338:1317–8.Search in Google Scholar

10. Krude H, Schutz B, Biebermann H, von Moers A, Schnabel D, et al. Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest 2002;109:475–80.Search in Google Scholar

11. Willemsen MA, Breedveld GJ, Wouda S, Otten BJ, Yntema JL, et al. Brain-Thyroid-Lung syndrome: a patient with a severe multi-system disorder due to a de novo mutation in the thyroid transcription factor 1 gene. Eur J Pediatr 2005;164:28–30.Search in Google Scholar

12. Carre A, Szinnai G, Castanet M, Sura-Trueba S, Tron E, et al. Five new TTF1/NKX2.1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case. Hum Mol Genet 2009;18:2266–76.Search in Google Scholar

13. Lapi P, Macchia PE, Chiovato L, Biffali E, Moschini L, et al. Mutations in the gene encoding thyroid transcription factor-1 (TTF-1) are not a frequent cause of congenital hypothyroidism (CH) with thyroid dysgenesis. Thyroid 1997;7:383–7.Search in Google Scholar

14. Gras D, Jonard L, Roze E, Chantot-Bastaraud S, Koht J, et al. Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene. J Neurol Neurosurg Psychiatry 2012;83:956–62.Search in Google Scholar

15. Doyle DA, Gonzalez I, Thomas B, Scavina M. Autosomal dominant transmission of congenital hypothyroidism, neonatal respiratory distress, and ataxia caused by a mutation of NKX2-1. J Pediatr 2004;145:190–3.Search in Google Scholar

16. Kusakabe T, Kawaguchi A, Hoshi N, Kawaguchi R, Hoshi S, et al. Thyroid-specific enhancer-binding protein/NKX2.1 is required for the maintenance of ordered architecture and function of the differentiated thyroid. Mol Endocrinol 2006;20:1796–809.Search in Google Scholar

17. Hamvas A, Deterding RR, Wert SE, White FV, Dishop MK, et al. Heterogeneous pulmonary phenotypes associated with mutations in the thyroid transcription factor gene NKX2-1. Chest 2013;144:794–804.Search in Google Scholar

18. Yuan B, Li C, Kimura S, Engelhardt RT, Smith BR, et al. Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. Dev Dyn 2000;217:180–90.Search in Google Scholar

19. Costa RH, Kalinichenko VV, Lim L. Transcription factors in mouse lung development and function. Am J Physiol Lung Cell Mol Physiol 2001;280:L823–38.Search in Google Scholar

20. Doriguzzi C, Palmucci L, Mongini T, Bresolin N, Bet L, et al. Endocrine involvement in mitochondrial encephalomyopathy with partial cytochrome c oxidase deficiency. J Neurol Neurosurg Psychiatry 1989;52:122–5.Search in Google Scholar

21. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 34–1987. A 30-year-old woman with an ocular motility disturbance, myopathy, and hypocalcemia. N Engl J Med 1987;317: 493–501.Search in Google Scholar

22. Balestri P, Grosso S. Endocrine disorders in two sisters affected by MELAS syndrome. J Child Neurol 2000;15:755–8.Search in Google Scholar

23. Lau KK, Yang SP, Haddad MN, Butani L, Makker SP. Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes syndrome with hypothyroidism and focal segmental glomerulosclerosis in a paediatric patient. Int Urol Nephrol 2007;39:941–6.Search in Google Scholar

24. Kaufmann P, Engelstad K, Wei Y, Kulikova R, Oskoui M, et al. Protean phenotypic features of the A3243G mitochondrial DNA mutation. Arch Neurol 2009;66:85–91.Search in Google Scholar

25. Medda E, Olivieri A, Stazi MA, Grandolfo ME, Fazzini C, et al. Risk factors for congenital hypothyroidism: results of a population case-control study (1997–2003). Eur J Endocrinol 2005;153:765–73.Search in Google Scholar

26. Barnett CP, Mencel JJ, Gecz J, Waters W, Kirwin SM, et al. Choreoathetosis, congenital hypothyroidism and neonatal respiratory distress syndrome with intact NKX2-1. Am J Med Genet A 2012;158A:3168–73.Search in Google Scholar

27. Van Vliet G. Development of the thyroid gland: lessons from congenitally hypothyroid mice and men. Clin Genet 2003;63:445–55.Search in Google Scholar

28. Vassart G, Dumont JE. Thyroid dysgenesis: multigenic or epigenetic... or both? Endocrinology 2005;146:5035–7.Search in Google Scholar

Received: 2013-3-19
Accepted: 2013-8-21
Published Online: 2013-10-16
Published in Print: 2014-03-01

©2014 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Images in pediatric endocrinology
  4. Leprechaunism (Donohue syndrome): report of a case in a newborn
  5. Original articles
  6. Children and adolescents with type 1 diabetes in Germany are more overweight than healthy controls: results comparing DPV database and CrescNet database
  7. Age of onset of pubertal maturation of Thai boys
  8. Plasma leptin and adiponectin concentrations correlate with cardiometabolic risk and systemic inflammation in healthy, non-obese children
  9. Early differentiation between good and poor response to growth hormone therapy in short children born small for gestational age (SGA) to improve the outcome of poor responders
  10. Children and adolescents with type 1 diabetes mellitus have a sixfold greater risk for prolonged QTc interval
  11. Effect of micronutrient supplementation on height velocity of underprivileged girls in comparison with un-supplemented healthy controls
  12. Insulin resistance in young adults born small for gestational age (SGA)
  13. The effect of childhood obesity on cardiac functions
  14. Adiponectin serum concentrations in newborn at delivery appear to be of fetal origin
  15. Thalassaemic Osteopathy: a cross-sectional preliminary study from Sri Lanka
  16. Health-related quality of life in Turner syndrome and the influence of key features
  17. Clinical analysis on 33 patients with hypothalamic syndrome in Chinese children
  18. The relationship between thyroid dose and diagnosis of primary hypothyroidism in pediatric brain tumor patients receiving craniospinal irradiation
  19. Molecular characterization of Chilean patients with a clinical diagnosis of Noonan syndrome
  20. Expensive therapies in children: benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential
  21. The absence of mutations in homeobox candidate genes HOXA3, HOXB3, HOXD3 and PITX2 in familial and sporadic thyroid hemiagenesis
  22. A truncating DUOX2 mutation (R434X) causes severe congenital hypothyroidism
  23. Heterozygous GHR gene mutation in a child with idiopathic short stature
  24. A novel compound mutation of CYP27B1 in a Chinese family with vitamin D-dependent rickets type 1A
  25. A de novo mutation of DAX1 in a boy with congenital adrenal hypoplasia without hypogonadotropic hypogonadism
  26. Patient reports
  27. Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature
  28. Preterm ovarian hyperstimulation syndrome presented with vaginal bleeding: a case report
  29. Pituitary stalk lesion in a 13-year-old female
  30. Radiologic manifestation of a BCS1L-mutated patient
  31. Permanent neonatal diabetes mellitus caused by a novel mutation in the KCNJ11 gene
  32. NKX2-1 mutations in brain-lung-thyroid syndrome: a case series of four patients
  33. A teenage boy with hypocalcemia after radioablation for Graves’ disease
  34. Short communication
  35. A common thyroid peroxidase gene mutation (G319R) in Turkish patients with congenital hypothyroidism could be due to a founder effect
  36. Letter to the Editor
  37. Endometriosis and migraine: what is there behind the scenes?
  38. 10.1515/jpem-2014-0999
Downloaded on 27.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0109/html?srsltid=AfmBOoquh2X-ZgK1TEsG5zLmyXQ4g6GoRfCcAOq0Dk4QIo3mXoWEEdzM
Scroll to top button